Sign In
Buy VNRX
$2.08
-0.240 (-10.34%)
At Close: Jun 03, 2026
Study shows Nu.Q® Lung Cancer Test differentiated malignant and benign nodules found by Low Dose CT screening
08:00am, Tuesday, 10'th Dec 2024
HENDERSON, Nev. , Dec. 10, 2024 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announced the results of a large-scale study which sh
VolitionRx Announces Pricing of up to $1.9 Million Registered Direct Offering
09:00am, Friday, 06'th Dec 2024
Up to $1.9 million up front with up to an additional $2.7 million of potential aggregate gross proceeds upon the exercise in full of common stock purchase warrants HENDERSON, Nev , Dec. 6, 2024 /PRNew
VolitionRx Limited (VNRX) Q3 2024 Earnings Call Transcript
11:47am, Friday, 15'th Nov 2024
VolitionRx Limited (NYSE:VNRX ) Q3 2024 Earnings Conference Call November 15, 2024 8:30 AM ET Company Participants Louise Batchelor - Chief Marketing & Communications Officer Tom Butera - CEO, Volitio
VolitionRx Limited Announces Third Quarter 2024 Financial Results and Business Update
04:10pm, Thursday, 14'th Nov 2024
Conference call to discuss financial and operational results scheduled for Friday, November 15 at 8:30 a.m. U.S. Eastern Time HENDERSON, Nev.
VolitionRx Limited Schedules Third Quarter 2024 Earnings Conference Call and Business Update
08:00am, Friday, 08'th Nov 2024
Conference call to take place on Friday, November 15 at 8:30 a.m. U.S Eastern Time HENDERSON, Nev.
Volition Appoints Timothy I. Still as Chairman
04:10pm, Wednesday, 06'th Nov 2024
HENDERSON, Nev. , Nov. 6, 2024 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has appointed Timothy Still as Chairman of its board of dir
Multiple studies show Nu.Q® NETs test could predict sepsis patients at risk of deteriorating
08:00am, Thursday, 31'st Oct 2024
HENDERSON, Nev. , Oct. 31, 2024 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has published a report , from its 'NETs in sepsis manageme
Volition to share new 'NETs in sepsis management' data insights at upcoming webinar
08:00am, Wednesday, 09'th Oct 2024
HENDERSON, Nev. , Oct. 9, 2024 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, is taking part in a webinar hosted by Edison Group, to expou
Volition hosts NETs in sepsis management symposium at ESICM Lives 2024
08:00am, Thursday, 03'rd Oct 2024
HENDERSON, Nev. , Oct. 3, 2024 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, is hosting a symposium at ESICM Lives 2024 in Barcelona on O
Volition Appoints Dr. Ethel Rubin as an Independent Director
04:10pm, Monday, 30'th Sep 2024
HENDERSON, Nev. , Sept. 30, 2024 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has appointed Dr. Ethel Rubin to its board of directors,
Volition Hosts KOL Roundtable on Sepsis
08:00am, Wednesday, 11'th Sep 2024
HENDERSON, Nev. , Sept. 11, 2024 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, hosted a Key Opinion Leader ("KOL") roundtable in Paris th
VolitionRx Limited (VNRX) Q2 2024 Earnings Call Transcript
12:11pm, Thursday, 15'th Aug 2024
VolitionRx Limited (NYSE:VNRX ) Q2 2024 Earnings Conference Call August 15, 2024 8:30 AM ET Company Participants Louise Batchelor - Chief Marketing and Communications Officer Cameron Reynolds - Presid
VolitionRx Limited Announces Second Quarter 2024 Financial Results and Business Update
04:10pm, Wednesday, 14'th Aug 2024
Conference call to discuss financial and operational results scheduled for Thursday, August 15 at 8:30 a.m. U.S. Eastern Time HENDERSON, Nev.
VolitionRx Announces Pricing of up to $21.5 Million Registered Direct Offering
08:00am, Friday, 09'th Aug 2024
$7 million upfront with up to an additional $14.5 million of potential aggregate gross proceeds upon the exercise in full of milestone-linked warrants HENDERSON, Nev. , Aug. 9, 2024 /PRNewswire/ -- Vo
VolitionRx Limited Schedules Second Quarter 2024 Earnings Conference Call and Business Update
08:00am, Tuesday, 06'th Aug 2024
Conference call to take place on Thursday August 15 at 8:30 a.m. U.S Eastern Time HENDERSON, Nev.
